Perfil
Bruce N.
Rogers is currently the President at Morphic Therapeutic, Inc. He previously worked as the Head-Neuro Opportunities at Pfizer Inc. from 2014 to 2016 and as a Scientist at Pharmacia & Upjohn Co. LLC from 1998 to 2003.
Additionally, he served as the President at Morphic Holding, Inc. in 2024.
Dr. Rogers holds a doctorate degree from the University of California, Irvine and an undergraduate degree from the University of Minnesota.
Cargos activos de Bruce Rogers
| Empresas | Cargo | Inicio |
|---|---|---|
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Presidente | 01/05/2022 |
Antiguos cargos conocidos de Bruce Rogers.
| Empresas | Cargo | Fin |
|---|---|---|
| MORC HOLD | Director Ejecutivo | 02/01/2024 |
| PFIZER INC. | Corporate Officer/Principal | 01/01/2016 |
Pharmacia & Upjohn Co. LLC
Pharmacia & Upjohn Co. LLC Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical goods | Corporate Officer/Principal | 01/08/2003 |
Formación de Bruce Rogers.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia & Upjohn Co. LLC
Pharmacia & Upjohn Co. LLC Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical goods | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Health Technology |
Morphic Holding, Inc.
Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
- Bolsa de valores
- Insiders
- Bruce Rogers
















